Tricarbonylrhenium(I) complexes of phosphine-derivatized amines, amino acids and a model peptide: structures, solution behavior and cytotoxicity
Files
529.2Kb
Citation
Export citationZhang, J., Vittal, J. J., Henderson, W., Wheaton, J. R., Hall, I. H., Hor, T. S. A., & Yan, Y. K. (2002). Tricarbonylrhenium(I) complexes of phosphine-derivatized amines, amino acids and a model peptide: structures, solution behavior and cytotoxicity. Journal of Organometallic Chemistry, 650(1/2), 123-132.
Permanent Research Commons link: https://hdl.handle.net/10289/3399
Abstract
Modified Mannich reactions of amines, amino acids and a model peptide with Ph₂PH and CH₂O gave bis(diphenylphosphinomethyl)amines (Ph₂PCH₂)₂NR [R=Ph (1), CH₂CH₂OH (2), CH₂COOCH₂Ph (3), CH₂CONHCH₂COOCH₂Ph (4), CH2COOH (5)] and (Ph₂PCH₂)₂NCH₂CH₂N(CH₂PPh₂)₂ (6). Reaction with [ReBr₃(CO)₃]²⁻ under mild conditions led to [ReBr(CO)₃]{(Ph₂PCH₂)₂NR} [R=Ph (7), CH₂CH₂OH (8), CH₂COOCH₂Ph (9), CH₂CONHCH₂COOCH₂Ph (10), CH₂COOH (11)] and [ReBr(CO)₃(Ph₂PCH₂)₂NCH₂]₂ (12). All new complexes have been characterized by NMR and IR spectroscopy and for 7, 9 and 10, single-crystal X-ray diffraction analyses. Electrospray mass spectrometric studies show that the rhenium–phosphine chelates are very stable, especially in neutral methanolic solution. Hydrolysis of the ester and amide linkages slowly occur in acidic and basic solutions over several weeks; displacement of the bromide ligand also occurs in basic medium. Cytotoxicity testing of 7–10 and 12 showed that all the complexes are active against specific tumor cell lines, especially MCF-7 breast cancer and HeLa-S3 suspended uterine carcinoma.
Date
2002Type
Publisher
Elsevier Science
Rights
This is an author’s accepted version of an article published in the Journal of Organometallic Chemistry. Copyright © 2002 Elsevier Science B.V. All rights reserved.